 | • レポートコード：MRC2-11QY11235 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はがんセラピューティクス・バイオセラピューティクスのグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、ホルモン療法、生物療法）市場規模、用途別（消費（販売）、家庭、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別がんセラピューティクス・バイオセラピューティクスの競争状況、市場シェア ・世界のがんセラピューティクス・バイオセラピューティクス市場：種類別市場規模 2015年-2020年（化学療法、放射線療法、ホルモン療法、生物療法） ・世界のがんセラピューティクス・バイオセラピューティクス市場：種類別市場規模予測 2021年-2026年（化学療法、放射線療法、ホルモン療法、生物療法） ・世界のがんセラピューティクス・バイオセラピューティクス市場：用途別市場規模 2015年-2020年（消費（販売）、家庭、病院） ・世界のがんセラピューティクス・バイオセラピューティクス市場：用途別市場規模予測 2021年-2026年（消費（販売）、家庭、病院） ・北米のがんセラピューティクス・バイオセラピューティクス市場分析：米国、カナダ ・ヨーロッパのがんセラピューティクス・バイオセラピューティクス市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのがんセラピューティクス・バイオセラピューティクス市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のがんセラピューティクス・バイオセラピューティクス市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのがんセラピューティクス・バイオセラピューティクス市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bristol-Myers Squibb、AstraZeneca、Pfizer、Biogen IDEC、Sanofi、Genentech、Novartis、Johnson & Johnson、Roche and Schering-Plough ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The global cancer therapeutics and biotherapeutics market is drived by the introduction of products such as gemcitabin, oxaliplatin and pemetrexed.
The increasing occurrence of different types of cancer and the increasing proliferation of new players in this market are expected to boost the development of global cancer therapeutics and biotherapeutics market.
Market Analysis and Insights: Global Cancer Therapeutics And Biotherapeutics Market
The global Cancer Therapeutics And Biotherapeutics market size is projected to reach US$ 9118.3 million by 2026, from US$ 8707.3 million in 2020, at a CAGR of 4.4%% during 2021-2026.
Global Cancer Therapeutics And Biotherapeutics Scope and Market Size
Cancer Therapeutics And Biotherapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Therapeutics And Biotherapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bristol-Myers Squibb
AstraZeneca
Pfizer
Biogen IDEC
Sanofi
Genentech
Novartis
Johnson & Johnson
Roche and Schering-Plough
Market segment by Type, the product can be split into
Chemotherapy
Radiation Therapy
Hormone Therapy
Biotherapy
Market segment by Application, split into
Consumption (Sales)
Household
Hospital
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Therapeutics And Biotherapeutics Revenue
1.4 Market by Type
1.4.1 Global Cancer Therapeutics And Biotherapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Radiation Therapy
1.4.4 Hormone Therapy
1.4.5 Biotherapy
1.5 Market by Application
1.5.1 Global Cancer Therapeutics And Biotherapeutics Market Share by Application: 2020 VS 2026
1.5.2 Consumption (Sales)
1.5.3 Household
1.5.4 Hospital
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cancer Therapeutics And Biotherapeutics Market Perspective (2015-2026)
2.2 Global Cancer Therapeutics And Biotherapeutics Growth Trends by Regions
2.2.1 Cancer Therapeutics And Biotherapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Therapeutics And Biotherapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Therapeutics And Biotherapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cancer Therapeutics And Biotherapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Cancer Therapeutics And Biotherapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cancer Therapeutics And Biotherapeutics Players by Market Size
3.1.1 Global Top Cancer Therapeutics And Biotherapeutics Players by Revenue (2015-2020)
3.1.2 Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Cancer Therapeutics And Biotherapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Therapeutics And Biotherapeutics Market Concentration Ratio
3.2.1 Global Cancer Therapeutics And Biotherapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cancer Therapeutics And Biotherapeutics Revenue in 2019
3.3 Cancer Therapeutics And Biotherapeutics Key Players Head office and Area Served
3.4 Key Players Cancer Therapeutics And Biotherapeutics Product Solution and Service
3.5 Date of Enter into Cancer Therapeutics And Biotherapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Therapeutics And Biotherapeutics Historic Market Size by Type (2015-2020)
4.2 Global Cancer Therapeutics And Biotherapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020)
5.2 Global Cancer Therapeutics And Biotherapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cancer Therapeutics And Biotherapeutics Market Size (2015-2020)
6.2 Cancer Therapeutics And Biotherapeutics Key Players in North America (2019-2020)
6.3 North America Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020)
6.4 North America Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cancer Therapeutics And Biotherapeutics Market Size (2015-2020)
7.2 Cancer Therapeutics And Biotherapeutics Key Players in Europe (2019-2020)
7.3 Europe Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020)
7.4 Europe Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020)
8 China
8.1 China Cancer Therapeutics And Biotherapeutics Market Size (2015-2020)
8.2 Cancer Therapeutics And Biotherapeutics Key Players in China (2019-2020)
8.3 China Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020)
8.4 China Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cancer Therapeutics And Biotherapeutics Market Size (2015-2020)
9.2 Cancer Therapeutics And Biotherapeutics Key Players in Japan (2019-2020)
9.3 Japan Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020)
9.4 Japan Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size (2015-2020)
10.2 Cancer Therapeutics And Biotherapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020)
11 India
11.1 India Cancer Therapeutics And Biotherapeutics Market Size (2015-2020)
11.2 Cancer Therapeutics And Biotherapeutics Key Players in India (2019-2020)
11.3 India Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020)
11.4 India Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cancer Therapeutics And Biotherapeutics Market Size (2015-2020)
12.2 Cancer Therapeutics And Biotherapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020)
12.4 Central & South America Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Details
13.1.2 Bristol-Myers Squibb Business Overview
13.1.3 Bristol-Myers Squibb Cancer Therapeutics And Biotherapeutics Introduction
13.1.4 Bristol-Myers Squibb Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020))
13.1.5 Bristol-Myers Squibb Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview
13.2.3 AstraZeneca Cancer Therapeutics And Biotherapeutics Introduction
13.2.4 AstraZeneca Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Cancer Therapeutics And Biotherapeutics Introduction
13.3.4 Pfizer Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Biogen IDEC
13.4.1 Biogen IDEC Company Details
13.4.2 Biogen IDEC Business Overview
13.4.3 Biogen IDEC Cancer Therapeutics And Biotherapeutics Introduction
13.4.4 Biogen IDEC Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020)
13.4.5 Biogen IDEC Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview
13.5.3 Sanofi Cancer Therapeutics And Biotherapeutics Introduction
13.5.4 Sanofi Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 Genentech
13.6.1 Genentech Company Details
13.6.2 Genentech Business Overview
13.6.3 Genentech Cancer Therapeutics And Biotherapeutics Introduction
13.6.4 Genentech Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020)
13.6.5 Genentech Recent Development
13.7 Novartis
13.7.1 Novartis Company Details
13.7.2 Novartis Business Overview
13.7.3 Novartis Cancer Therapeutics And Biotherapeutics Introduction
13.7.4 Novartis Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020)
13.7.5 Novartis Recent Development
13.8 Johnson & Johnson
13.8.1 Johnson & Johnson Company Details
13.8.2 Johnson & Johnson Business Overview
13.8.3 Johnson & Johnson Cancer Therapeutics And Biotherapeutics Introduction
13.8.4 Johnson & Johnson Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020)
13.8.5 Johnson & Johnson Recent Development
13.9 Roche and Schering-Plough
13.9.1 Roche and Schering-Plough Company Details
13.9.2 Roche and Schering-Plough Business Overview
13.9.3 Roche and Schering-Plough Cancer Therapeutics And Biotherapeutics Introduction
13.9.4 Roche and Schering-Plough Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020)
13.9.5 Roche and Schering-Plough Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cancer Therapeutics And Biotherapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Therapeutics And Biotherapeutics Revenue
Table 3. Ranking of Global Top Cancer Therapeutics And Biotherapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Therapeutics And Biotherapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Radiation Therapy
Table 7. Key Players of Hormone Therapy
Table 8. Key Players of Biotherapy
Table 9. Global Cancer Therapeutics And Biotherapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Cancer Therapeutics And Biotherapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Cancer Therapeutics And Biotherapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Cancer Therapeutics And Biotherapeutics Market Share by Regions (2015-2020)
Table 13. Global Cancer Therapeutics And Biotherapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Cancer Therapeutics And Biotherapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Cancer Therapeutics And Biotherapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Cancer Therapeutics And Biotherapeutics Players
Table 20. Global Cancer Therapeutics And Biotherapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Cancer Therapeutics And Biotherapeutics Market Share by Players (2015-2020)
Table 22. Global Top Cancer Therapeutics And Biotherapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Therapeutics And Biotherapeutics as of 2019)
Table 23. Global Cancer Therapeutics And Biotherapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Cancer Therapeutics And Biotherapeutics Product Solution and Service
Table 26. Date of Enter into Cancer Therapeutics And Biotherapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Cancer Therapeutics And Biotherapeutics Market Size Share by Type (2015-2020)
Table 30. Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Cancer Therapeutics And Biotherapeutics Market Size Share by Application (2015-2020)
Table 32. Global Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Cancer Therapeutics And Biotherapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Cancer Therapeutics And Biotherapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Cancer Therapeutics And Biotherapeutics Market Share (2019-2020)
Table 36. North America Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Cancer Therapeutics And Biotherapeutics Market Share by Type (2015-2020)
Table 38. North America Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Cancer Therapeutics And Biotherapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Cancer Therapeutics And Biotherapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Cancer Therapeutics And Biotherapeutics Market Share (2019-2020)
Table 42. Europe Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Cancer Therapeutics And Biotherapeutics Market Share by Type (2015-2020)
Table 44. Europe Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Cancer Therapeutics And Biotherapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Cancer Therapeutics And Biotherapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Cancer Therapeutics And Biotherapeutics Market Share (2019-2020)
Table 48. China Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Cancer Therapeutics And Biotherapeutics Market Share by Type (2015-2020)
Table 50. China Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Cancer Therapeutics And Biotherapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Cancer Therapeutics And Biotherapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Cancer Therapeutics And Biotherapeutics Market Share (2019-2020)
Table 54. Japan Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Cancer Therapeutics And Biotherapeutics Market Share by Type (2015-2020)
Table 56. Japan Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Cancer Therapeutics And Biotherapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Cancer Therapeutics And Biotherapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Cancer Therapeutics And Biotherapeutics Market Share (2019-2020)
Table 60. Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Cancer Therapeutics And Biotherapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Cancer Therapeutics And Biotherapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Cancer Therapeutics And Biotherapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Cancer Therapeutics And Biotherapeutics Market Share (2019-2020)
Table 66. India Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Cancer Therapeutics And Biotherapeutics Market Share by Type (2015-2020)
Table 68. India Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Cancer Therapeutics And Biotherapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Cancer Therapeutics And Biotherapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Cancer Therapeutics And Biotherapeutics Market Share (2019-2020)
Table 72. Central & South America Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Cancer Therapeutics And Biotherapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Cancer Therapeutics And Biotherapeutics Market Share by Application (2015-2020)
Table 76. Bristol-Myers Squibb Company Details
Table 77. Bristol-Myers Squibb Business Overview
Table 78. Bristol-Myers Squibb Product
Table 79. Bristol-Myers Squibb Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020) (Million US$)
Table 80. Bristol-Myers Squibb Recent Development
Table 81. AstraZeneca Company Details
Table 82. AstraZeneca Business Overview
Table 83. AstraZeneca Product
Table 84. AstraZeneca Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020) (Million US$)
Table 85. AstraZeneca Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Product
Table 89. Pfizer Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020) (Million US$)
Table 90. Pfizer Recent Development
Table 91. Biogen IDEC Company Details
Table 92. Biogen IDEC Business Overview
Table 93. Biogen IDEC Product
Table 94. Biogen IDEC Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020) (Million US$)
Table 95. Biogen IDEC Recent Development
Table 96. Sanofi Company Details
Table 97. Sanofi Business Overview
Table 98. Sanofi Product
Table 99. Sanofi Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020) (Million US$)
Table 100. Sanofi Recent Development
Table 101. Genentech Company Details
Table 102. Genentech Business Overview
Table 103. Genentech Product
Table 104. Genentech Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020) (Million US$)
Table 105. Genentech Recent Development
Table 106. Novartis Company Details
Table 107. Novartis Business Overview
Table 108. Novartis Product
Table 109. Novartis Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020) (Million US$)
Table 110. Novartis Recent Development
Table 111. Johnson & Johnson Business Overview
Table 112. Johnson & Johnson Product
Table 113. Johnson & Johnson Company Details
Table 114. Johnson & Johnson Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020) (Million US$)
Table 115. Johnson & Johnson Recent Development
Table 116. Roche and Schering-Plough Company Details
Table 117. Roche and Schering-Plough Business Overview
Table 118. Roche and Schering-Plough Product
Table 119. Roche and Schering-Plough Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020) (Million US$)
Table 120. Roche and Schering-Plough Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Therapeutics And Biotherapeutics Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Hormone Therapy Features
Figure 5. Biotherapy Features
Figure 6. Global Cancer Therapeutics And Biotherapeutics Market Share by Application: 2020 VS 2026
Figure 7. Consumption (Sales) Case Studies
Figure 8. Household Case Studies
Figure 9. Hospital Case Studies
Figure 10. Cancer Therapeutics And Biotherapeutics Report Years Considered
Figure 11. Global Cancer Therapeutics And Biotherapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cancer Therapeutics And Biotherapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Cancer Therapeutics And Biotherapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cancer Therapeutics And Biotherapeutics Market Share by Players in 2019
Figure 16. Global Top Cancer Therapeutics And Biotherapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Therapeutics And Biotherapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cancer Therapeutics And Biotherapeutics Revenue in 2019
Figure 18. North America Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…- 頭頸部がん治療薬の世界市場（～2026年） Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…
- 肺がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Therapeutics Market The global Lung Cancer Therapeutics market size is projected to reach US$ 15800 million by 2026, from US$ 14180 million in 2020, at a CAGR of 10.6%% during 2021-2026. Global Lung Cancer Therapeutics Scope and Market Size Lung Cance…
- 膀胱がん治療・診断の世界市場（～2026年） The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the inner…
- 去勢抵抗性前立腺がん治療の世界市場（～2026年） Prostate cancer can be defined as it is a form of cancer that develops into male reproductive system. Most of the prostate cancer are slow growing and stable but sometimes it can spread from prostate (gland) to other part of body such as bone and lymph node. Initially prostate cancer does not pose a…